Yoshiyasu Nakamura

2.1k total citations
71 papers, 1.6k citations indexed

About

Yoshiyasu Nakamura is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yoshiyasu Nakamura has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Yoshiyasu Nakamura's work include Cancer Cells and Metastasis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (6 papers). Yoshiyasu Nakamura is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (6 papers). Yoshiyasu Nakamura collaborates with scholars based in Japan, United States and China. Yoshiyasu Nakamura's co-authors include Yohei Miyagi, Mitsuyo Yoshihara, Yuji Sakuma, Shiro Koizume, Eiju Tsuchiya, Yoichi Kameda, Masaoki Harada, Etsuko Miyagi, Shoichi Matsukuma and Tomoyuki Yokose and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Yoshiyasu Nakamura

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiyasu Nakamura Japan 25 650 528 398 325 231 71 1.6k
Yasuo Hirono Japan 23 616 0.9× 505 1.0× 410 1.0× 254 0.8× 159 0.7× 112 1.7k
Carsten Grüllich Germany 25 557 0.9× 493 0.9× 479 1.2× 188 0.6× 168 0.7× 90 1.5k
Michele Quaranta Italy 24 596 0.9× 644 1.2× 198 0.5× 457 1.4× 203 0.9× 57 1.6k
L Holubec Czechia 23 732 1.1× 930 1.8× 371 0.9× 666 2.0× 185 0.8× 92 2.0k
G. Deplanque France 23 633 1.0× 1.3k 2.4× 812 2.0× 542 1.7× 132 0.6× 77 2.3k
Elena De Mattia Italy 25 725 1.1× 963 1.8× 324 0.8× 279 0.9× 71 0.3× 92 2.0k
Frauke Bentzien United States 10 821 1.3× 665 1.3× 522 1.3× 298 0.9× 93 0.4× 12 2.1k
Marco Pizzi Italy 28 910 1.4× 463 0.9× 385 1.0× 629 1.9× 153 0.7× 124 2.2k
Chunyi Hao China 24 724 1.1× 871 1.6× 493 1.2× 330 1.0× 248 1.1× 135 2.1k
W. Grigioni Italy 24 636 1.0× 725 1.4× 642 1.6× 604 1.9× 320 1.4× 59 2.3k

Countries citing papers authored by Yoshiyasu Nakamura

Since Specialization
Citations

This map shows the geographic impact of Yoshiyasu Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyasu Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyasu Nakamura more than expected).

Fields of papers citing papers by Yoshiyasu Nakamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyasu Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyasu Nakamura. The network helps show where Yoshiyasu Nakamura may publish in the future.

Co-authorship network of co-authors of Yoshiyasu Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyasu Nakamura. A scholar is included among the top collaborators of Yoshiyasu Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyasu Nakamura. Yoshiyasu Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ota, Yukihide, Yukio Suzuki, Shiro Koizume, et al.. (2024). Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study. BMC Cancer. 24(1). 1058–1058. 2 indexed citations
2.
Kasajima, Rika, Koichi Azuma, Tomoyuki Tagami, et al.. (2024). Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma. Frontiers in Immunology. 15. 1361992–1361992. 3 indexed citations
3.
Sato, Shinya, Toru Hiruma, Mitsuyo Yoshihara, et al.. (2023). Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Science. 114(6). 2674–2688. 17 indexed citations
4.
Ota, Yukihide, et al.. (2022). A practical spatial analysis method for elucidating the biological mechanisms of cancers with abdominal dissemination in vivo. Scientific Reports. 12(1). 20303–20303. 1 indexed citations
5.
Nakayama, Hirotaka, Kae Kawachi, Nobuyasu Suganuma, et al.. (2020). EZH2 and MMSET Were Identified as Potentially Useful Therapeutic Targets in Metaplastic Breast Carcinoma. Anticancer Research. 40(4). 2133–2139. 5 indexed citations
6.
Kim, Hyonchol, Yoshiyasu Nakamura, Akihiro Hattori, et al.. (2019). Size Distribution Analysis with On-Chip Multi-Imaging Cell Sorter for Unlabeled Identification of Circulating Tumor Cells in Blood. Micromachines. 10(2). 154–154. 5 indexed citations
7.
Kawai, Kenji, Akira Noguchi, Hidemitsu Sato, et al.. (2015). Establishment of patient-derived cancer xenografts in immunodeficient NOG mice. International Journal of Oncology. 47(1). 61–70. 44 indexed citations
8.
Kim, Hyonchol, Hideyuki Terazono, Yoshiyasu Nakamura, et al.. (2014). Development of On-Chip Multi-Imaging Flow Cytometry for Identification of Imaging Biomarkers of Clustered Circulating Tumor Cells. PLoS ONE. 9(8). e104372–e104372. 23 indexed citations
9.
Yokota, Naho, Mikiko Asai‐Sato, Roppei Yamada, et al.. (2013). Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells. PLoS ONE. 8(11). e80359–e80359. 40 indexed citations
10.
Sakuma, Yuji, Shoichi Matsukuma, Yoshiyasu Nakamura, et al.. (2013). Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells. Laboratory Investigation. 93(10). 1137–1146. 43 indexed citations
11.
Yoshii, Takako, Yohei Miyagi, Yoshiyasu Nakamura, et al.. (2013). Pilot Research for the Correlation between the Expression Pattern of E-cadherin-β-Catenin Complex and Lymph Node Metastasis in Early Gastric Cancer. Tumori Journal. 99(2). 234–238. 10 indexed citations
12.
Koizume, Shiro, Shin Ito, Etsuko Miyagi, et al.. (2012). HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII- gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Research. 40(12). 5389–5401. 40 indexed citations
13.
Koizume, Shiro, Naho Yokota, Etsuko Miyagi, et al.. (2009). Hepatocyte Nuclear Factor-4–Independent Synthesis of Coagulation Factor VII in Breast Cancer Cells and Its Inhibition by Targeting Selective Histone Acetyltransferases. Molecular Cancer Research. 7(12). 1928–1936. 38 indexed citations
14.
Dehari, Reiko, Yoshiyasu Nakamura, Naoyuki Okamoto, & Hiroki Nakayama. (2008). Increased Nuclear Expression of Growth Hormone Receptor in Uterine Cervical Neoplasms of Women under 40 Years Old. The Tohoku Journal of Experimental Medicine. 216(2). 165–172. 9 indexed citations
15.
Sakuma, Yuji, Naoyuki Okamoto, Haruhiro Saito, et al.. (2008). A logistic regression predictive model and the outcome of patients with resected lung adenocarcinoma of 2 cm or less in size. Lung Cancer. 65(1). 85–90. 7 indexed citations
16.
Sakuma, Yuji, Shoichi Matsukuma, Mitsuyo Yoshihara, et al.. (2007). Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung. Modern Pathology. 20(9). 967–973. 24 indexed citations
17.
Sakuma, Yuji, Shoichi Matsukuma, Mitsuyo Yoshihara, et al.. (2007). Distinctive Evaluation of Nonmucinous and Mucinous Subtypes of Bronchioloalveolar Carcinomas inEGFRand K-rasGene-Mutation Analyses for Japanese Lung Adenocarcinomas. American Journal of Clinical Pathology. 128(1). 100–108. 106 indexed citations
18.
Nishimura, Goshi, et al.. (2000). An Experimental Model of Tumor Dormancy Therapy for Advanced Head and Neck Carcinoma. Japanese Journal of Cancer Research. 91(11). 1199–1203. 11 indexed citations
19.
Tarao, Kazuo, Hiroshi Hoshino, Akio Shimizu, et al.. (1994). Role of Increased DNA Synthesis Activity of Hepatocytes in Multicentric Hepatocarcinogenesis in Residual Liver of Hepatectomized Cirrhotic Patients with Hepatocellular Carcinoma. Japanese Journal of Cancer Research. 85(10). 1040–1044. 30 indexed citations
20.
Shimizu, Akio, Yoshiyasu Nakamura, Masaoki Harada, et al.. (1989). Positive Foci of Glutathione S‐Transferase Placental Form in the Liver of Rats Given Furfural by Oral Administration. Japanese Journal of Cancer Research. 80(7). 608–611. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Hirono Breakdown of academic impact, for papers by Carsten Grüllich Breakdown of academic impact, for papers by Michele Quaranta Breakdown of academic impact, for papers by L Holubec Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Elena De Mattia Breakdown of academic impact, for papers by Frauke Bentzien Breakdown of academic impact, for papers by Marco Pizzi Breakdown of academic impact, for papers by Chunyi Hao Breakdown of academic impact, for papers by W. Grigioni
Rankless by CCL
2026